Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rotavirus vaccines: an overview

K Midthun1, A Z Kapikian

  • 1Division of Vaccines and Related Products Application, Food and Drug Administration, Rockville, Maryland 20852, USA.

Clinical Microbiology Reviews
|July 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

More on RotaShield and intussusception: the role of age at the time of vaccination.

The Journal of infectious diseases·2005
Same author

Lessons from preventive infectious disease vaccines.

Developments in biologicals·2004
Same author

Detection and genotyping of human group A rotaviruses by oligonucleotide microarray hybridization.

Journal of clinical microbiology·2002
Same author

Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants.

Vaccine·2001
Same author

A rotavirus vaccine for prevention of severe diarrhoea of infants and young children: development, utilization and withdrawal.

Novartis Foundation symposium·2001
Same author

Transfusion-associated hepatitis not due to viral hepatitis type A or B. 1975.

Reviews in medical virology·2001

Developing oral rotavirus vaccines aims to prevent severe diarrhea in infants. Early vaccines showed variable protection, prompting research into multivalent approaches targeting key rotavirus serotypes.

Area of Science:

  • Vaccinology
  • Virology
  • Pediatrics

Background:

  • Live attenuated rotavirus strains delivered orally are the focus of vaccine development.
  • Initial rotavirus vaccines (bovine, rhesus) were safe and immunogenic but offered inconsistent protection against rotavirus diarrhea.
  • Preventing severe rotavirus-induced dehydration in infants is a global health priority.

Purpose of the Study:

  • To evaluate the efficacy of multivalent rotavirus vaccines for protecting infants against severe rotavirus diarrhea.
  • To explore the potential of human-animal rotavirus reassortants as vaccine candidates.
  • To assess the necessity of targeting multiple VP7 serotypes for broad infant protection.

Main Methods:

  • Development of human-animal rotavirus reassortants with human VP7 genes and animal parent genes.

Related Experiment Videos

  • Clinical trials of a quadrivalent reassortant vaccine (RRV and serotypes 1, 2, 4) in the United States and Peru.
  • Investigation of human-bovine reassortant vaccines, including those with human VP4 genes.

    • Main Results:

    • A quadrivalent reassortant rotavirus vaccine demonstrated promising preliminary efficacy in the US.
    • Rotavirus vaccine efficacy in Peru showed only limited protection.
    • Human-animal reassortant vaccines are under continued investigation.

    Conclusions:

    • Multivalent rotavirus vaccines targeting key VP7 serotypes are a promising strategy for infant protection.
    • Further research into human-animal reassortant rotavirus vaccines is ongoing.
    • Optimizing rotavirus vaccine formulations is crucial for global public health.